ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It offers anti-infective drugs, anti-allergic drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, antidepressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Mezlocillin sodium sulbactam sodium for injection, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Flouxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Smectite powder, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as provides DNA gene preservation services. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to ShanXi C&Y Pharmaceutical Group Co.,LTD. in September 2014. ShanXi C&Y Pharmaceutical Group Co.,LTD. was founded in 2005 and is headquartered in Datong, China.